Navigation Links
Micropharma completes development of first microbiome clinical lab test using digital PCR technology
Date:10/23/2013

itive and negative droplets are numbered in a droplet counter to produce the final result. Dr. Ganopolsky was quoted as saying "The technique is so sensitive that can detect only one copy of the gene without false positives". In addition, the accuracy of droplet digital PCR is up to 10 times higher than the traditional qPCR, which is necessary in this type of analysis. Micropharma aims to expand the development of the SenseIT platform which represents the first approach to personalized medicine tests based on microbiome analysis.

About Micropharma Limited

Micropharma is a Canadian biotechnology company focused on human health through the microbiome. The company applies a unique approach, ProSelect, to the discovery and commercialization of novel products based on the human microbiome for the diagnosis and treatment of metabolic diseases.  Micropharma works on disease specific products with clear microbiome related mechanisms, and links to biomarkers that are associated with improving human health.  Micropharma is developing diagnostics and oral biologic therapies in the area of metabolic disease including hypercholesterolemia, metabolic syndrome, obesity, and diabetes.  For more info go to www.micropharma.net

Media Contact: Mitchell Jones, Micropharma Limited, 514-927-5333, mitchell@micropharma.net

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Micropharma Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Micropharma Convenes Expert Roundtable on New Role for Probiotics in Cardiovascular Disease in time for National Cholesterol Education Month
2. Micropharma announces timeline to commercial launch of worlds first ingestible gastrointestinal sampling device
3. Micropharma Limited announces new agreement to commercialize novel natural health products
4. Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising
5. InnoPharma Completes $15 Million Series A Financing
6. Aratana Therapeutics Completes $15 Million Series B Financing
7. CeNeRx BioPharma Completes $4.85 Million Financing
8. PDL BioPharma Completes Regular Quarterly Dividend Payment
9. MiMedx Group Completes $5,000,000 Private Placement
10. goBalto Completes a Successful FDA 21 CFR Part 11 Compliance Audit
11. Auxogyn Completes $20 Million In Series A Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... FL (PRWEB) , ... August 31, 2015 , ... ... bring together the world's most successful food and beverage processors, equipment manufacturers and ... competencies in product inspection and industrial weighing and formulation for manufacturers of bakery ...
(Date:8/30/2015)... , August 31, 2015 , ... Frau   für chirurgische   Behandlung     ... 7-90   werden für eine   verheerende   Geburtsverletzung ... behandeln und die Anzahl ausgebildeter Chirurgen in Kenia bis ... gab heute bekannt, dass  Action on Fistula  seit ihrem ...
(Date:8/28/2015)... ... August 28, 2015 , ... Proove Biosciences , ... International Spine Intervention Society’ s 23rd Annual Scientific Meeting (ASM). The ... With a focus on evidence-based research and clinical application, the event gathered industry ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... Wade McKenna, DO, announced today that the use of sterile, dehydrated amniotic tissue ... healing of an otherwise non-healing surgical knee wound. , The case involved a ...
Breaking Biology Technology:METTLER TOLEDO Hosts Food Safety Educational Center at 2015 PROCESS EXPO 2Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 2Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 3Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 4Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 5Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 2Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 3Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 4Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 2Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 3Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 4
... Verenium Corporation (Nasdaq: VRNM ), ... high-performance industrial enzyme solutions, today announced that it ... a high performance enzyme for the saccharification of ...  The DELTAZYM® GA L-E5 enzyme has demonstrated high ...
... a three-hospital health system providing care to ... management system provided by Surgical Information Systems ... into the hospitals, existing Siemens Soarian® system ... and drive business results. (Logo: ...
... MISSISSAUGA, ON, Sept. 29 /PRNewswire-FirstCall/ - YM BioSciences ... Pulmokine Inc. (Slingerlands, New York), a licensee of ... awarded two National Institutes of Health (NIH) Small ... more than US$650,000, are Phase I awards to ...
Cached Biology Technology:Verenium Launches DELTAZYM® GA L-E5 Enzyme for Fuel Ethanol Production 2Verenium Launches DELTAZYM® GA L-E5 Enzyme for Fuel Ethanol Production 3Susquehanna Health Selects Perioperative and Anesthesia Automation Solution from Surgical Information Systems 2Susquehanna Health Selects Perioperative and Anesthesia Automation Solution from Surgical Information Systems 3Susquehanna Health Selects Perioperative and Anesthesia Automation Solution from Surgical Information Systems 4YM BioSciences licensee Pulmokine awarded NIH funding to develop small molecule drugs for pulmonary hypertension 2YM BioSciences licensee Pulmokine awarded NIH funding to develop small molecule drugs for pulmonary hypertension 3
(Date:7/31/2015)... La 10e Conférence internationale sur la ... le BGI du 22 au 25 octobre 2015 ... La conférence célèbre son 10e anniversaire ... est devenue l,une des réunions annuelles mondiales les ... c,est aussi la plus dynamique, la plus enthousiaste ...
(Date:7/31/2015)... Jul. 31, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market and creator ... filed provisional patent 62/198989 for ELECTRONIC CRYPTO-CURRENCY ... a method to advance crypto-currencies such as Bitcoin into ... common, uniform way to manage all payments.  ...
(Date:7/27/2015)... , July 27, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced that Huawei has selected ... solution for its stylish smartwatch. Huawei chose the ... reliability, low power and highly responsive human interface ... Huawei designers also required a classic round watch ...
Breaking Biology News(10 mins):La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3
... . , A tip about a folk ... off bugs has led to the discovery of insect-repelling ... identified components of Jatropha curcas seed oil ... Agricultural Research Service (ARS) Natural Products Utilization Research Unit ...
... Approximately one-third of Americans take a daily multivitamin, but little ... Now, new research from Brigham and Women,s Hospital (BWH) ... of cardiovascular disease in men. A similar BWH study, ... man,s risk of cancer by 8 percent. The cardiovascular ...
... move their facial whiskers back and forth about eight times ... acquire this sense? And if they can, what could understanding ... about how humans normally sense? At the Weizmann Institute, researchers ... of blindfolded volunteers and asking them to carry out a ...
Cached Biology News:Daily multivitamin use does not reduce cardiovascular disease risk in men 2Learning a new sense 2Learning a new sense 3
... catalyzes the degradation of single-stranded DNA and ... While the nuclease prefers ssDNA over dsDNA ... enzyme degrades double-stranded DNA from both ends ... for transcript mapping studies (3,4), for flushing ...
... The S.c. EasyComp Transformation Kit is ... Saccharomyces cerevisiae cells. Advantages over commonly ... formation or LiCl methods include:- Cells can ... 30 minutes - Competent cell preparation and ...
Endomorphin-2. Cross reactivity: Endomorphin-1 3%, Met-enkephalin <0.03%, Leu-enkephalin <0.01% and beta-Endorphin <0.01%....
...
Biology Products: